CLINICAL ROLE -
Community Pharmacists Can Help Monitor, Manage Cardiometabolic Parameters in Schizophrenia
Health care professionals providing care to patients using second-generation antipsychotics could benefit from incorporating community pharmacists as members of their team.
Read More
Eliminating Hepatitis C Virus Infections in Individuals who Inject Drugs: A Novel Model of Community Pharmacy Care
In this model, community pharmacists deliver all aspects of treating HCV infection in individuals who inject drugs.
Updating Hospital Policies to Improve Inpatient Care for Patients With Parkinson Disease
Hospital pharmacists can play an important role in advocating for, designing, and implementing various policies to optimize care.
Clinical Overview: Empagliflozin for Type 2 Diabetes Patients With Cardiovascular Disease or Heart Failure, Reduced Ejection Fraction
Empagliflozin has been found to lower the risk of death due to cardiovascular events and the number of first and recurrent heart failure hospitalizations.
Clincial Overview: Olopatadine Extra Strength for Treating Ocular Itching Due to Allergic Conjunctivitis
Olopatadine stabilizes ocular mast cells to prevent histamine release by allergens.
Clinical Overview: Inclisiran for Heterozygous Familial Hypercholesterolemia or Atherosclerotic Cardiovascular Disease
Inclisiran (Leqvio) is a small interfering ribonucleic acid approved by the FDA for patients who are on a maximally-tolerated dose of statins and need additional LDL-C reduction.
Clinical Overview: Dhivy for Treating Parkinson Disease or its Manifestations Due to Viral, Environmental Toxins
Dhivy is a levodopa/carbidopa combination formulation approved by the FDA in November 2021 for the treatment of Parkinson disease or manifestations due to viral or environmental exposures.
